Drug Research
Therapure Biomanufacturing Signs Manufacturing Deal With VBI Vaccines for...
Therapure Biomanufacturing, a division of Therapure Biopharma Inc., announced today the signing of an agreement with VBI Vaccines Inc. for the manufacture of their coronavirus...
Clinical Trials
SAB Biotherapeutics Announces First Participant Dosed In Phase 1...
SAB Biotherapeutics (SAB), a clinical stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high potency, fully human polyclonal antibodies without the...
Press Releases
FUJIFILM Diosynth Biotechnologies expands its partnership with Novavax to...
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announce that its site in Billingham,...
Press Releases
FDA Approves Roche’s ENSPRYNG for Neuromyelitis Optica Spectrum Disorder
Roche announced that the US FDA has approved ENSPRYNGâ„¢ (satralizumab-mwge) as the first and only subcutaneous treatment for adults living with anti-aquaporin-4 (AQP4) antibody positive...
Drug Research
Memo Therapeutics and Northway Biotech collaborate on the fast-track...
Swiss biotech company Memo Therapeutics AG (MTx), and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to...
Press Releases
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION...
TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform,...
Press Releases
Biological E. Limited Acquires Akorn India
Biological E. Limited, a Hyderabad-based pharmaceuticals & Biologics company, announced the acquisition of Akorn India Limited, a subsidiary of Akorn Inc., USA.
By this strategic acquisition,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.